Showing results (131-140 of 237) with videos related to
Sort By:
Pageof 24
Urologic Oncology|December 17, 2008
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell linesHervé Wallerand, Ying Cai, Zev A Wainberg, et al.Breast Cancer Research : BCR|August 4, 2018
Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growthYuzhi Wang, Jun Zhang, Lele Wu, et al.Cells|June 10, 2022
Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC)Katyana Amilca-Seba, Tuan Zea Tan, Jean-Paul Thiery, et al.Oncoimmunology|March 28, 2017
Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicityStéphane Terry, Stéphanie Buart, Tuan Zea Tan, et al.BMC Cancer|May 21, 2024
The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of pyruvate in adenoma-carcinoma transition of human colorectal cancerJing-Yu Wang, Xiao-Ping Zhang, Hong-Kun Zhou, et al.Oncotarget|September 12, 2015
Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinomaKian Ngiap Chua, Li Ren Kong, Wen Jing Sim, et al.Oncotarget|January 22, 2015
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progressionShiyi Yu, Xiuxiu Cai, Chenxi Wu, et al.Development (Cambridge, England)|January 10, 2002
Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryoArnaud André Mailleux, Bradley Spencer-Dene, Christian Dillon, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockadeMaria L Lotsberg, Austin Rayford, Jean Paul Thiery, et al.Theranostics|August 2, 2021
Emerging role of circulating tumor cells in immunotherapyAlexey Rzhevskiy, Alina Kapitannikova, Polina Malinina, et al.Pageof 24